Terms: = Endocrine gland cancer AND EZR, CVIL, 7430, ENSG00000092820, P15311, MGC1584, FLJ26216, DKFZp762H157, CVL AND Diagnosis
4 results:
1. Serum anti-CFL1, anti-ezr, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.
Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P
Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875
[TBL] [Abstract] [Full Text] [Related]
2. Nomograms predict survival outcomes for distant metastatic pancreatic neuroendocrine tumor: A population based STROBE compliant study.
Li G; Tian ML; Bing YT; Wang HY; Yuan CH; Xiu DR
Medicine (Baltimore); 2020 Mar; 99(13):e19593. PubMed ID: 32221079
[TBL] [Abstract] [Full Text] [Related]
3. Autoantibody-targeted TAAs in pancreatic cancer: A comprehensive analysis.
Zhou Y; Cui J; Du H
Pancreatology; 2019 Jul; 19(5):760-768. PubMed ID: 31255446
[TBL] [Abstract] [Full Text] [Related]
4. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
[TBL] [Abstract] [Full Text] [Related]
